Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Hims & Hers Health (DE:82W)
FRANKFURT:82W
Holding DE:82W?
Track your performance easily
See the Price Targets and Ratings of:
82W Analyst Ratings
Hold
4 Buy
7 Hold
1 Sell
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers in the past 3 months
82W Stock 12 Month Forecast
Average Price Target
€22.92
▼(-0.08% Downside)
| Highest Price Target€30.56 | Average Price Target€22.92 | Lowest Price Target€15.28 |
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.
Detailed List of Analyst Forecasts
Ranks
Any
Analyst Rating
Any
Upside/ Downside
Any
Action
Any
Truist Financial
Reiterated
11/22/24
TD Cowen
Reiterated
11/20/24
Bank of America Securities
Downgraded
11/14/24
Leerink Partners
Reiterated
11/14/24
Deutsche Bank
Reiterated
11/06/24
Seaport Global
Reiterated
11/05/24
Needham
Reiterated
11/05/24
Piper Sandler
Reiterated
11/05/24
Canaccord Genuity
Reiterated
11/04/24
Robert W. Baird
€15.28
Hold
-33.39%
Downside
Reiterated
11/04/24
Analysts Have Conflicting Sentiments on These Healthcare Companies: Cigna (NYSE: CI), Hims & Hers Health (NYSE: HIMS) and MannKind (NASDAQ: MNKD)
Jefferies
€17.19
Hold
-25.06%
Downside
Reiterated
10/14/24
Hold Rating Maintained Amidst Strong Performance and Market Volatility: Glen Santangelo's Analysis on Hims & Hers Health
Imperial Capital
€15.28→€16.24
Hold
-29.22%
Downside
Downgraded
08/09/24
Hims & Hers downgraded to In-Line at Imperial Capital earlier this weekHims & Hers downgraded to In-Line at Imperial Capital earlier this week
Tigress Financial
€18.15
Buy
-20.90%
Downside
Reiterated
02/29/24
Hims & Hers Health: A Strong Buy on Accelerated Growth and Market Positioning
Guggenheim
€14.33→€16.24
Buy
-29.22%
Downside
Reiterated
02/27/24
We are incrementally more positive on HIMS after a solid 4Q print and even better outlook given by management, Guggenheim analyst Jack Wallace wrote in a research note after the earnings were disclosed on Monday.
Best Analysts Covering Hims & Hers Health
Which Analyst Should I Follow If I Want to Buy DE:82W and Sell After:
1 Month
xxx
Success Rate
4/7 ratings generated profit
Average Return
+1.37%
reiterated a xxx
rating 9 months ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 1 Month would result in 57.14% of your transactions generating a profit, with an average return of +1.37% per trade.
3 Months
xxx
Success Rate
9/12 ratings generated profit
Average Return
+20.99%
downgraded a xxx
rating 9 days ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 3 Months would result in 75.00% of your transactions generating a profit, with an average return of +20.99% per trade.
1 Year
Success Rate
7/7 ratings generated profit
Average Return
+97.54%
reiterated a buy rating 9 months ago
Copying Jack Wallace's trades and holding each position for 1 Year would result in 100.00% of your transactions generating a profit, with an average return of +97.54% per trade.
2 Years
xxx
Success Rate
7/7 ratings generated profit
Average Return
+174.70%
reiterated a xxx
rating 9 months ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 2 Years would result in 100.00% of your transactions generating a profit, with an average return of +174.70% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.
82W Analyst Recommendation Trends
Rating
Jul 24
Aug 24
Sep 24
Oct 24
Nov 24
Strong Buy
2
1
1
1
1
Buy
11
11
9
9
8
Hold
13
14
12
16
16
Sell
0
0
0
0
1
Strong Sell
0
0
0
0
0
total
26
26
22
26
26
Each month's total comprises the sum of three months' worth of ratings.
82W Financial Forecast
82W Stock Forecast FAQ
What is DE:82W’s average 12-month price target, according to analysts?
Based on analyst ratings, Hims & Hers Health’s 12-month average price target is €22.92.
What is DE:82W’s upside potential, based on the analysts’ average price target?
Currently there's no upside potential for DE:82W, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
How can I follow the stock ratings of top Wall Street analysts?
Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
Is Hims & Hers Health a Buy, Sell or Hold?
Hims & Hers Health has a consensus rating of Hold, which is based on 4 buy ratings, 7 hold ratings and 1 sell ratings.
What is Hims & Hers Health’s share price target?
The average share price target for Hims & Hers Health is €22.92. This is based on 12 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
The highest analyst share price target is €30.56 ,and the lowest forecast is €15.28. The average share price target represents -0.08% Decrease from the current price of €22.94.
The highest analyst share price target is €30.56 ,and the lowest forecast is €15.28. The average share price target represents -0.08% Decrease from the current price of €22.94.
What do analysts say about Hims & Hers Health?
Hims & Hers Health’s analyst rating consensus is a Hold. This is based on the ratings of 12 Wall Streets Analysts.
How can I buy shares of Hims & Hers Health?
To buy shares of DE:82W, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.